Time to reconsider the role of ribavirin in lassa fever

55Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.

Cite

CITATION STYLE

APA

Salam, A. P., Cheng, V., Edwards, T., Olliaro, P., Sterne, J., & Horby, P. (2021). Time to reconsider the role of ribavirin in lassa fever. PLoS Neglected Tropical Diseases, 15(7). https://doi.org/10.1371/journal.pntd.0009522

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free